Related Experiment Video
Updated: Jul 14, 2026

Imaging of mtHyPer7, a Ratiometric Biosensor for Mitochondrial Peroxide, in Living Yeast Cells
Published on: June 2, 2023
Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidants
Mitchell P Fink1, Carlos A Macias, Jingbo Xiao
1Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States. finkmp@ccm.upmc.edu
Abstract:
Oxidative damage to various cellular constituents (such as, proteins and lipids) mediated by reactive oxygen species (ROS) is thought to be an important mechanism underlying the pathogenesis of a variety of acute and chronic diseases. Mitochondria are the main source of ROS within most cells. Accordingly, there is increasing interest in the development of pharmacological ROS scavengers, which are specifically targeted to and concentrated within mitochondria. Numerous compounds with these general characteristics have been synthesized and evaluated in a variety of in vitro and in vivo models of redox stress. Among the more promising of these mitochondria-targeted anti-oxidants are those that employ various peptides (or peptide-like moieties) derived from the antibiotic, gramicidin S, as the targeting construct and employ the stable free radical, 4-amino-2,2,6,6-tetramethylpiperidine-N-oxyl (4-NH(2)-TEMPO), as the ROS scavenging "payload." One of these hemigramicidin-TEMPO conjugates, XJB-5-131, has been shown to ameliorate intestinal mucosal injury and prolong survival in rats subjected to lethal hemorrhage.
Insights
Mitochondria-targeted antioxidants, like XJB-5-131, can scavenge harmful reactive oxygen species (ROS). This compound protected against intestinal injury and improved survival in rats experiencing severe bleeding.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Reactive oxygen species (ROS) cause cellular damage, contributing to disease.
- Mitochondria are a primary source of ROS, making them a key target for intervention.
- Developing targeted ROS scavengers for mitochondria is crucial for treating redox-related diseases.
Purpose of the Study:
- To evaluate mitochondria-targeted antioxidants for their potential in combating oxidative stress.
- To investigate the efficacy of gramicidin S-derived peptide conjugates with 4-amino-2,2,6,6-tetramethylpiperidine-N-oxyl (4-NH(2)-TEMPO) as ROS scavengers.
- To assess the protective effects of XJB-5-131 against oxidative damage in disease models.
Main Methods:
- Synthesis and evaluation of hemigramicidin-TEMPO conjugates as mitochondria-targeted antioxidants.
- In vitro and in vivo testing in models of redox stress.
- Assessment of intestinal mucosal injury and survival rates in rats subjected to lethal hemorrhage.
Main Results:
- XJB-5-131, a hemigramicidin-TEMPO conjugate, demonstrated potent ROS scavenging capabilities.
- The compound effectively ameliorated intestinal mucosal injury in a rat hemorrhage model.
- Administration of XJB-5-131 significantly prolonged survival in rats subjected to lethal hemorrhage.
Conclusions:
- Mitochondria-targeted antioxidants, exemplified by XJB-5-131, show significant therapeutic potential.
- Targeting ROS within mitochondria offers a promising strategy for treating acute and chronic diseases.
- XJB-5-131 represents a viable candidate for further development in managing conditions involving oxidative stress and hemorrhage.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of Bacterial DNA Synthesis
Mitochondrial Membranes
Inhibitors of Bacterial Protein Synthesis
Antifungal Agents
